Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Thioredoxin reductase | 0.0038 | 0.0139 | 0.0316 |
Mycobacterium tuberculosis | Probable reductase | 0.0088 | 0.3769 | 0.8342 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.4382 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0088 | 0.3769 | 0.8342 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0062 | 0.1854 | 0.1854 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0038 | 0.0139 | 0.5 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0096 | 0.4382 | 0.5 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0097 | 0.4491 | 1 |
Brugia malayi | Melibiase family protein | 0.0069 | 0.2422 | 0.5527 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0104 | 0.4978 | 0.4978 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0039 | 0.0177 | 0.0177 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0062 | 0.1854 | 0.3544 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0062 | 0.1854 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0172 | 1 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0038 | 0.0139 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.4382 | 1 |
Echinococcus multilocularis | geminin | 0.0172 | 1 | 1 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.0104 | 0.4978 | 0.4978 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0096 | 0.4382 | 0.4382 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0104 | 0.4978 | 0.4978 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0096 | 0.4382 | 0.4382 |
Plasmodium vivax | glutathione reductase, putative | 0.0038 | 0.0139 | 0.5 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0069 | 0.2422 | 0.4516 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0104 | 0.4978 | 0.4978 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.4382 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0039 | 0.0177 | 0.0177 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0062 | 0.1854 | 0.1854 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0104 | 0.4978 | 0.4978 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0097 | 0.4491 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.4382 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0096 | 0.4382 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0062 | 0.1854 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0062 | 0.1854 | 0.1854 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.4382 | 1 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.0104 | 0.4978 | 0.4978 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.0104 | 0.4978 | 0.4978 |
Plasmodium falciparum | glutathione reductase | 0.0038 | 0.0139 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.2422 | 0.5381 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0096 | 0.4382 | 0.4382 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0096 | 0.4382 | 1 |
Schistosoma mansoni | kinase | 0.0049 | 0.0901 | 0.0901 |
Giardia lamblia | Kinase, PLK | 0.0096 | 0.4382 | 0.5 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0097 | 0.4491 | 1 |
Toxoplasma gondii | melibiase subfamily protein | 0.0104 | 0.4978 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0069 | 0.2422 | 0.2422 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.4382 | 1 |
Brugia malayi | glutathione reductase | 0.0038 | 0.0139 | 0.0316 |
Trypanosoma brucei | polo-like protein kinase | 0.0096 | 0.4382 | 1 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0088 | 0.3769 | 0.8342 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0096 | 0.4382 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0172 | 1 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0062 | 0.1854 | 0.5 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0088 | 0.3769 | 0.8342 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0096 | 0.4382 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0062 | 0.1854 | 0.3941 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0062 | 0.1854 | 0.4042 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0097 | 0.4491 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0096 | 0.4382 | 1 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0096 | 0.4382 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0069 | 0.2422 | 0.2422 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0088 | 0.3769 | 0.8342 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0096 | 0.4382 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0062 | 0.1854 | 0.1854 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0088 | 0.3769 | 0.8342 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 23.85 uM | Inhibition of recombinant human farnesyltransferase using Dansyl-GCVLS as substrate measured for 15 mins by fluorimetric analysis | ChEMBL. | 24054122 |
Inhibition (binding) | = 77 % | Inhibition of recombinant human farnesyltransferase using Dansyl-GCVLS as substrate at 100 uM measured for 15 mins by fluorimetric analysis relative to control | ChEMBL. | 24054122 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.